Upico Medicare Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 16-11-2024
- Paid Up Capital ₹ 1.00 M
as on 16-11-2024
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
as on 16-11-2024
- Revenue -12.02%
(FY 2023)
- Profit -48.25%
(FY 2023)
- Ebitda -1.31%
(FY 2023)
- Net Worth 315.40%
(FY 2023)
- Total Assets 8.78%
(FY 2023)
About Upico Medicare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.00 M.
Ashish Goyal and Asha Garg serve as directors at the Company.
- CIN/LLPIN
U33301DL2018PTC334244
- Company No.
334244
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Upico Medicare Private Limited offer?
Upico Medicare Private Limited offers a wide range of products and services, including Surgical & Medical Consumables, Surgical Disposables, Adhesive & Pressure Sensitive Tapes, Decorative Tape, Forceps & Graspers, Surgical Clamps, Surgical & ICU Equipments, Oxygen Mask, Flowmeter & Humidifier Bottle, Infusion Syringes & Supplies, Catheter.
Who are the key members and board of directors at Upico Medicare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Goyal  | Director | 22-May-2018 | Current |
| Asha Garg | Director | 22-May-2018 | Current |
Financial Performance of Upico Medicare.
Upico Medicare Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.02% decrease. The company also saw a substantial fall in profitability, with a 48.25% decrease in profit. The company's net worth Soared by an impressive increase of 315.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Upico Medicare?
In 2023, Upico Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 29 Oct 2020 | ₹4.00 M | Open |
How Many Employees Work at Upico Medicare?
Unlock and access historical data on people associated with Upico Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Upico Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Upico Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
